Medicina Serum as a pharmaceutical products Company was established to complete the treatment package of Iranian Dialysis Consortium in 2015 for patients with renal failure with the mission of producing and supplying peritoneal dialysis solutions as well as injectable and therapeutic serums for medical use in hospitals and medical centers. . In this regard, with great efforts, it has been able to obtain the exclusive representation of peritoneal dialysis products of the German company (Fresenius Medical Care) in 2017.
Another services of Medicina Serum Company is the provision of Continuous Renal Replacement Therapy (CRRT) products and related medical services, for which purpose it has obtained the exclusive representation of these products from the Fresenius Medical Care Company in 2018.
The vision of Medicina Serum Company is to have an effective role in the prevention and treatment of patients with high quality products in accordance with international standards and up-to-date technology. And in a certain period of time, by protecting human values, it brings maximum added value to the stakeholders (patients, customers, employees). In summary, the vision of Medicina Serum Company is as follows:
To carry out this mission, the company has appeared in the role of a capable research institution and supplier, and while investing and attracting the participation of leading foreign companies in developing participatory management and upgrading the scientific and technical level of its employees, will try to establish effective and coordinated communication, together with other related institutions, it has played a pivotal role in the production, supply, study and implementation of plans and projects and is complementary to sustainable national and regional development.
